"Multifactorial Risk Stratification in Acute and Chronic Cardiovascular Disease" ("riskINN ")

Medical University Innsbruck2 sites in 1 country5,000 target enrollmentJanuary 1, 2021

ConditionsCardiovascular Diseases Healthy

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Cardiovascular Diseases
Sponsor: Medical University Innsbruck
Enrollment: 5000
Locations: 2
Primary Endpoint: combination of cardiovascular mortality, stroke, myocardial infarction and hospitalization due to decompensated heart failure
Status: Recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The aim of this study is to develop risk prediction models for the early detection of high-risk patients with structural, rhythmological or inflammatory cardiovascular diseases.

Registry

clinicaltrials.gov

Start Date

January 1, 2021

End Date

January 2030

Last Updated

last year

Study Type

Observational

Sex

All

Investigators

Sponsor

Medical University Innsbruck

Responsible Party

Principal Investigator

Univ. Prof. Dr. Axel Bauer

Univ.-Prof. Dr.

Medical University Innsbruck

Eligibility Criteria

Inclusion Criteria

•Decision-eligible male and female patients ≥18 years of age
•Acute or chronic condition due to structural, rhythmologic, or inflammatory cardiovascular disease
•Informed consent for participation in the clinical trial

Exclusion Criteria

•missing infromed consent
•pregnant or breast-feeding women

Outcomes

Primary Outcomes

combination of cardiovascular mortality, stroke, myocardial infarction and hospitalization due to decompensated heart failure

Time Frame: from inclusion to end of study (max. 4 years)

Secondary Outcomes

hospitalization due to decompensated heart failure(from inclusion to end of study (max. 4 years))
severe arrythmic events(from inclusion to end of study (max. 4 years))
cardiovascular mortality(from inclusion to end of study (max. 4 years))
hospitalization due to cardiovascular condition(from inclusion to end of study (max. 4 years))
admission to intensive care unit(from inclusion to end of study (max. 4 years))
myocardial infarction(from inclusion to end of study (max. 4 years))
total mortality(from inclusion to end of study (max. 4 years))
stroke(from inclusion to end of study (max. 4 years))